Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.0247 | 0.5907 | 0.5907 |
Trypanosoma brucei | mitogen-activated protein kinase 3, putative | 0.0247 | 0.5907 | 0.5 |
Leishmania major | mitogen-activated protein kinase 3, putative,map kinase 3, putative | 0.0247 | 0.5907 | 0.5 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.0247 | 0.5907 | 0.5 |
Echinococcus multilocularis | 0.0181 | 0.3629 | 0.3629 | |
Schistosoma mansoni | protein kinase | 0.0257 | 0.6256 | 1 |
Echinococcus granulosus | protein kinase | 0.0181 | 0.3629 | 0.3629 |
Echinococcus multilocularis | tumor protein p63 | 0.0364 | 1 | 1 |
Schistosoma mansoni | protein kinase | 0.0181 | 0.3629 | 0.5801 |
Echinococcus granulosus | mitogen activated protein kinase 14 | 0.0247 | 0.5907 | 0.5907 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.0247 | 0.5907 | 0.5907 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.0247 | 0.5907 | 0.5907 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.0247 | 0.5907 | 0.5907 |
Loa Loa (eye worm) | STE/STE20/MSN protein kinase | 0.0181 | 0.3629 | 0.586 |
Loa Loa (eye worm) | CMGC/MAPK/P38 protein kinase | 0.0247 | 0.5907 | 0.9539 |
Brugia malayi | probable protein kinase | 0.0257 | 0.6256 | 1 |
Echinococcus granulosus | mitogen activated protein kinase 11 | 0.0247 | 0.5907 | 0.5907 |
Brugia malayi | P38 map kinase family protein 2 | 0.0247 | 0.5907 | 0.9442 |
Loa Loa (eye worm) | hypothetical protein | 0.0255 | 0.6192 | 1 |
Echinococcus granulosus | serine:threonine protein kinase mig 15 | 0.0255 | 0.6192 | 0.6192 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.0247 | 0.5907 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.